Arkolith/Insider Trading/ACUR/Form 4

Jones Robert B

President & CEOACURA PHARMACEUTICALS, INC (ACUR) · full profile →Form 4 · filed Aug 5, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 3, 2022Option exercise(M)64K——554K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 3, 2022Option exercise(M)14K——140K
Aug 3, 2022Option exercise(M)50K——90K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-086713) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML